1. Home
  2. BCDA vs CAPT Comparison

BCDA vs CAPT Comparison

Compare BCDA & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

N/A

Current Price

$1.28

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

CAPT

Captivision Inc.

HOLD

Current Price

$0.42

Market Cap

13.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
CAPT
Founded
N/A
2005
Country
United States
South Korea
Employees
17
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
13.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCDA
CAPT
Price
$1.28
$0.42
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
60.5K
170.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.30
52 Week High
$3.20
$1.93

Technical Indicators

Market Signals
Indicator
BCDA
CAPT
Relative Strength Index (RSI) 48.26 42.57
Support Level $1.10 $0.40
Resistance Level $1.39 $0.46
Average True Range (ATR) 0.10 0.02
MACD 0.01 0.00
Stochastic Oscillator 40.96 32.34

Price Performance

Historical Comparison
BCDA
CAPT

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: